Radbook2012

DO YOU KNOW WHAT YOU’RE MISSING? Each dose matters. © 2011–2012 MEDRAD, INC. All rights reserved. BAYER and the Bayer Cross are registered trademarks of Bayer. MEDRAD®, Stellant® and Certegra™ are trademarks of the Bayer group of companies. Products in the Certegra™ Informatics Platform work in any combination with the MEDRAD Stellant® CT Injection System to: • Enable a higher percentage of diagnostic studies*2,3 – and reduced potential for unnecessary rescans3 • Allow radiologists to relate clinical-image evaluations to changes in prescribed protocols made at the point-of-care • Actively manage operational results 1 DF-119378 rev 01 2 Presented at Society of Thoracic Radiology (2008) Poster Session; Christopher R. Deible, MD, PhD. Study supported by MEDRAD 3 510(k) FDA clearance number: K082905 * At a slightly higher contrast dose when compared to a standard protocol of 80ml THE INDUSTRY’S FIRST 1 CONTRAST DOSE MANAGEMENT™ SOLUTION Eliminate busy work. Speed-up information flow. Rely on accurate data to reveal actionable insight. Now you can automatically document and integrate CT contrast-injection records into PACS; individualize contrast protocols at the point-of-care; and activate department-wide reporting throughout all shifts.